Abstract | AIMS: To compare the efficacy of platelet-rich plasma (PRP) injection vs dry needling (DN) for management of trigger points in the masseter muscle in myofascial pain syndrome (MPS) patients. METHODS: This randomized controlled trial included 30 clinically confirmed cases of myofascial trigger points (MTrPs) in the masseter muscle who were randomly and equally (1:1) assigned to the test (PRP) and control (DN) groups. Both groups were evaluated for pain (visual analog scale [VAS]), range of functional movements, need for pain medication, patient satisfaction (Likert scale), and sleep (VAS) at baseline and 2-week, 1-month, and 3-month follow-ups. VAS pain and Likert score were also obtained at 6-month intervals. RESULTS: The use of PRP solution in MTrPs in MPS patients had a better effect on pain and patient satisfaction compared to DN. CONCLUSION: PRP appears to be a more effective treatment modality compared to DN in the management of MTrPs in MPS patients.
|
Authors | Varsha Agarwal, Ambika Gupta, Harneet Singh, Mala Kamboj, Harsha Popli, Suman Saroha |
Journal | Journal of oral & facial pain and headache
(J Oral Facial Pain Headache)
Vol. 36
Issue 3-4
Pg. 253–262
( 2022)
ISSN: 2333-0376 [Electronic] United States |
PMID | 36445907
(Publication Type: Randomized Controlled Trial, Journal Article)
|
Topics |
- Humans
- Masseter Muscle
- Trigger Points
- Myofascial Pain Syndromes
(therapy)
- Platelet-Rich Plasma
- Pain
|